Company Profiles

driven by the PitchBook Platform

Presidio Pharmaceuticals

Description

Developer of small molecule antiviral therapeutics. The company focuses on the discovery, in-licensing, development and commercialization of therapeutics for viral infections.

2006

Founded

PRIVATE

Status

11-50

Employees

Series D

Latest Deal Type

$21.8M

Latest Deal Amount

$90.7M

Total Amount Raised

Description

Developer of small molecule antiviral therapeutics. The company focuses on the discovery, in-licensing, development and commercialization of therapeutics for viral infections.

Website:

www.presidiopharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery

Primary Office

1700 Owens Street Suite 585 San Francisco, CA 94158United States +1 (415) 655-7560
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Presidio Pharmaceuticals's full profile, request a free trial.

Presidio Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Presidio Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Presidio Pharmaceuticals Investors (9)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Baker Brothers InvestmentsPE/BuyoutMinority000 0000000 0000
Bay City CapitalVenture CapitalMinority000 0000000 0000
Crown Predator HoldingsVenture CapitalMinority000 0000000 0000
Five Corners CapitalVenture CapitalMinority000 0000000 0000
New Leaf Venture PartnersVenture CapitalMinority000 0000000 0000
Baker Brothers Investments PE/Buyout
Bay City Capital Venture Capital
Crown Predator Holdings Venture Capital
Five Corners Capital Venture Capital
New Leaf Venture Partners Venture Capital

Presidio Pharmaceuticals Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Leo RedmondChief Financial Officer, Board Member & Acting President
Richard Colonno Ph.DChief Scientific Officer
Joseph RobinsonDirector of Operations
Sherin Halfon Ph.DSenior Director, Product Development and Project Management
Leping LiVice President of Chemistry
Leo Redmond Chief Financial Officer, Board Member & Acting President
Richard Colonno Ph.D Chief Scientific Officer
Joseph Robinson Director of Operations
Sherin Halfon Ph.D Senior Director, Product Development and Project Management
Leping Li Vice President of Chemistry

Presidio Pharmaceuticals Board Members (9)

NameRepresentingRoleSinceContact
Info
Dayton MisfeldtBay City CapitalManaging Director & Partner000 0000
Farid GhazzaouiPresidio PharmaceuticalsBoard Member000 0000
Felix Baker Ph.DBaker Brothers InvestmentsCo-Founder & Managing Partner000 0000
H. Daniel Perez MDBay City CapitalAdvisor000 0000
Jack Obijeski Ph.DSelfBoard Member000 0000
Dayton Misfeldt Managing Director & Partner Bay City Capital
Farid Ghazzaoui Board Member Presidio Pharmaceuticals
Felix Baker Ph.D Co-Founder & Managing Partner Baker Brothers Investments
H. Daniel Perez MD Advisor Bay City Capital
Jack Obijeski Ph.D Board Member Self
Request full access to PitchBook